The Biotech Beat: Unpacking a Week of Breakthroughs, Billions, and Big Bets
Biotech's Pulse: Gene-Editing's Leap, Cancer's New Fights, and What's Stirring the Industry
The Great Weight Shift: Biotech's Quest for What's Next in Obesity Care
The Shadow Returns: What Trump's Drug Pricing Encore Means for Your Medicine Cabinet
Trump Unleashes Trade Weapon Against Global Partners Over 'Unfair' Drug Prices
Biotech's Vanguard: Novo Nordisk, Omeros, and GSK Charting New Territories in Medical Innovation
AstraZeneca's Landmark Deal: Lowering Drug Prices for Medicaid Under Trump Administration Agreement
Revolutionizing Healthcare: Trump's Bold Stance on Lowering Prescription Drug Costs
President Trump's Landmark Initiative to Tackle Skyrocketing Prescription Drug Costs
Trump's Bold New Blueprint: Unveiling Ambitious Plans to Slash Prescription Drug Costs
Rethinking Drug Costs: Trump's Bold Bid to Reshape Pharmaceutical Pricing
White House Shelves Generic Drug Tariffs, Paving the Way for Indian Pharma's Continued Success
Trump Extends Conditional Olive Branch to Democrats on Healthcare Amidst Shutdown Tensions
Trump's Pharma Tariffs: A Risky Gamble on American Innovation and Health
The Perilous Bargain: Are We Trading Future Cures for Today's Drug Savings?
Crucial Medicare Drug Price Loophole Fix Stalled: A Setback for Patient Savings
The Enduring Battle: Trump, Pfizer, and the Shifting Tides of Prescription Drug Pricing
TrumpRx Unveils Groundbreaking Platform to Dramatically Cut Prescription Drug Costs
Game Changer: Pfizer Secures Tariff Reprieve, Vows Lower Drug Prices for Millions of Americans
Pfizer's Bold New Chapter: Shares Soar as Pharma Giant Commits to Sweeping US Drug Price Cuts
Trump Hails Landmark Pfizer Deal: $70 Million US Investment and Drug Price Cuts Announced
Trump Hails "Historic" Deal with Pfizer to Drastically Cut Drug Prices
Trump's Bold Move: White House Pressures Pharma Giants for Lower Drug Prices
Trump's Landmark Drug Price Promise: A Deadline Vanished, Unnoticed
Trump's Bold Pharmaceutical Tariff Plan: Unpacking the 'America First' Drug Strategy
Trump's Bold Pharmaceutical Tariff Plan: Unpacking the Potential Impacts on America's Drug Supply
Trump's Tariff Gamble: Experts Unpack the Real Cost of Pharma Duties
US Tariffs Threaten India's Generic Pharma Powerhouse: Himachal Manufacturers Sound Alarm
Trump's Tariff Vision: A Risky Prescription for Soaring Drug Costs and Shaken Supply Chains
Trump's Audacious Pharma Tariff Gamble: Will American Drug Prices Skyrocket?
Trump's Bold Pharmaceutical Tariff: A 100% Game Changer?
Trump's Tariff Tempest: Why a 100% Drug Tax Could Sink India's Pharma Giants and Ignite a US Healthcare Crisis
Trump's Looming 100% Pharma Tariff: A Catastrophic Blow for India's Global Pharmacy?
Trump Unleashes 100% Tariff on Imported Branded Drugs, Shaking Up Global Pharma
AstraZeneca Unleashes Legal Barrage Against Medicare Drug Price Controls
The Enduring Saga of Drug Prices: Trump's Lingering Shadow on Healthcare Affordability
Kenvue's Remarkable Rebound: Shaking Off White House Pressure and Soaring Back
Historic Triumph for American Patients: Pharma Giant Levels Drug Prices Across US and Europe Following Trump's Relentless Advocacy
The Unseen Weight: Unpacking the Escalating Costs and Long-Term Dependency of Weight-Loss Jabs
The White House's 'Affordable Drugs' Website: A Digital Band-Aid on a Crushing Problem?
Novartis Plots Strategic Price Adjustments in US as Trump's MFN Deadline Looms
Trump Administration Unveils Sweeping Crackdown on Pharmaceutical Ad Transparency
Unmasking Big Pharma: Trump Administration Mandates Price Transparency in Drug Ads